![]() |
| (c) Cell Transplantation |
Retina Global is a US based 501(c)(3) nonprofit that is focused on finding sustainable solutions to the ever-increasing issues with retinal diseases in underserved areas around the world. We also manage the Orange County Eye Project in Santa Ana, CA.
Showing posts with label Retinopathy of Prematurity. Show all posts
Showing posts with label Retinopathy of Prematurity. Show all posts
Thursday, August 20, 2015
Amniotic membrane derived stem cell transplants show benefit in retinal diseases
Wednesday, July 15, 2015
Intravitreal bevacizumab appears to be safe in treatment of retinopathy of prematurity
The use of intravitreal bevacizumab appears to be safe in preterm infants for treatment of retinopathy of prematurity, according to a long-term multicenter study.
Friday, January 23, 2015
Telemedicine in premature babies with ROP
Retinopathy of prematurity (ROP) continues to be an ongoing challenge for both ophthalmologists and neonatologists and remains a significant threat to vision for extremely premature infants despite the availability of therapeutic modalities. It remains a leading cause of morbidity despite, (and interestingly) as well as because of, advances in neonatal care, which have improved survival rates of at-risk infants born prematurely. Many controlled clinical trials have shown that application of therapies at the appropriate time is essential to successful outcomes in premature infants affected by ROP.
Subscribe to:
Posts (Atom)
